Zdrowie i gospodarka · 29/07/2019
FDA Clears FORTAMET Extended-Release Tablets for Sale
The US Food and Drug Administration (FDA) has ruled that FORTAMET (metformin hydrochloride) extended-release tablets, 500mg and 1g, were not withdrawn from sale due to safety or effectiveness concerns, allowing the FDA to continue approving abbreviated new drug applications (ANDAs) for these products.